NASDAQ logo

NASDAQ
NASDAQ Composite

20,511
Loading...
Loading...
News
all
press releases
FRESHPET BECOMES FIRST DOG FOOD TO EARN CLEAN LABEL PROJECT CERTIFICATION
FRESHPET BECOMES FIRST DOG FOOD TO EARN CLEAN LABEL PROJECT CERTIFICATION FRESHPET BECOMES FIRST DOG FOOD TO EARN CLEAN LABEL PROJECT CERTIFICATION PR Newswire BEDMINSTER, N.J., Feb. 12, 2026 Only...
PR Newswire·4d ago
News Placeholder
More News
News Placeholder
Mammoth Announces Fourth-Quarter and Full-Year 2025 Conference Call
Mammoth Announces Fourth-Quarter and Full-Year 2025 Conference Call Mammoth Announces Fourth-Quarter and Full-Year 2025 Conference Call PR Newswire OKLAHOMA CITY, Feb. 5, 2026 OKLAHOMA CITY, Feb. 5...
PR Newswire·11d ago
News Placeholder
Atossa Therapeutics Maintains Strong Market Position for (Z)-Endoxifen for Duchenne Muscular Dystrophy as Congress Reauthorizes Priority Review Voucher Program
Atossa Therapeutics Maintains Strong Market Position for (Z)-Endoxifen for Duchenne Muscular Dystrophy as Congress Reauthorizes Priority Review Voucher Program Atossa Therapeutics Maintains Strong...
PR Newswire·11d ago
News Placeholder
What Drove US Indices Down Today?
Investors dumped technology stocks as they move to safer assets like Gold and Silver that rose today.
Stocktwits·13d ago
News Placeholder
S&P 500 Hits All Time Intraday High Ahead Of Fed’s First Policy Meeting Of 2026 This Week
As of 12:32 EST, the S&P 500 index rose nearly 0.5% to $6,983.65, while the Nasdaq Composite climbed nearly1%.
Stocktwits·20d ago
News Placeholder
Atossa Therapeutics' Founder and CEO Steven Quay, M.D., Ph.D. Named One of The Top 50 Healthcare Technology CEOs of 2025
Atossa Therapeutics' Founder and CEO Steven Quay, M.D., Ph.D. Named One of The Top 50 Healthcare Technology CEOs of 2025 Atossa Therapeutics' Founder and CEO Steven Quay, M.D., Ph.D. Named One of The...
PR Newswire·26d ago
News Placeholder
Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy
Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen...
PR Newswire·1mo ago
News Placeholder
How Do Interest Rates Affect Stock Markets?
Interest rate decisions by central banks influence borrowing costs, investor sentiment, and stock valuations across Wall Street.
Stocktwits·2mo ago
News Placeholder
Is The Stock Market Open On Dec 31? Here Are NYSE, Nasdaq Trading Hours On New Year’s Eve
As the curtain falls on 2025, U.S. equities are wrapping up a year marked by resilience, volatility, and shifting expectations around interest rates.
Stocktwits·2mo ago
News Placeholder
Is The Nasdaq Composite Getting Ready For A Short-Term Correction? Chart Shows A Lower High And Approach Toward 50-DMA
The index has formed a lower high of around 23,700 last Wednesday, compared to its peak of around 24,020 formed on October 29.
Stocktwits·2mo ago
<
1
2
...
>

Latest NASDAQ News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.